Pembrolizumab in HER2-positive gastric cancer Research Letter
| Authors: | Janjigian, Y. Y.; Kawazoe, A.; Bai, Y.; Xu, J.; Lonardi, S.; Metges, J. P.; YanĖez, P.; Wyrwicz, L. S.; Shen, L.; Ostapenko, Y.; Bilici, M.; Chung, H. C.; Shitara, K.; Qin, S.; Van Cutsem, E.; Tabernero, J.; Luo, S.; Mahave, M.; Tang, Y.; Lowery, M.; Monteiro, M. M. F.; Xu, L. Z.; Shih, C. S.; Sharan, K. P.; Bhagia, P.; Rha, S. Y. |
| Title: | Pembrolizumab in HER2-positive gastric cancer |
| Abstract: | Pembrolizumab in HER2-Positive Gastric Cancer The addition of pembrolizumab to trastuzumab and chemotherapy in patients with gastric cancer improved both progression-free and overall survival as compared with trastuzumab and chemotherapy alone. |
| Journal Title: | New England Journal of Medicine |
| Volume: | 391 |
| Issue: | 14 |
| ISSN: | 0028-4793 |
| Publisher: | Massachusetts Medical Society |
| Date Published: | 2024-10-10 |
| Start Page: | 1360 |
| End Page: | 1362 |
| Language: | English |
| ACCESSION: | WOS:001313402500001 |
| DOI: | 10.1056/NEJMc2408121 |
| PROVIDER: | wos |
| PUBMED: | 39282917 |
| Notes: | The MSK Cancer Center Support Grant (P30 CA008748) is acknowledge in the PDF -- Corresponding authors is MSK author: Yelena Y. Janjigian -- Source: Wos |
